Thirty-six patients who suffered a recurrence of thyrotoxicosis after subtotal  thyroidectomy have been retrospectively analysed. After 11 subsequent second  operations, 7 further relapses occurred while 2 patients had permanent recurrent  laryngeal nerve paralyses. Only 1 patient out of 18 treated with either long-term  neomercazole or betaadrenergic blockade remained in remission. Radio-active iodine is the treatment of choice in patients who relapse after surgery for thyrotoxicosis. A significant percentage of thyrotoxic patients treated by subtotal thyroidectomy have a recurrence of the hyperthyroid state.'" Attention has recently been focused on the management of such patients; in particular the poor results of surgery in such recurrent cases have been emphasized: This report concerns a retrospective analysis of the management of 36 thyrotoxic patients seen at Groote Schuur Hospital who had a  recurrence of hyperthyroidism after thyroidectomy

Baker, G.

Pimstone, B.

English

AJOL - African Journals Online

646 S.A. MEDICAL JOURNAL 12 June 1971THE MANAGEMENT OF RECURRENT THYROTOXICOSIS AFTER THYROIDECTOMY*G. BAKER, t M.B., CH.B. EC.S. (S.A.), ER.C.S. (EDIN,) AND B. PIMSTONE, M.D., M.R.C.P., Departments of Surgeryand Medicine, Groote Schuur Hospital and University of Cape TownSUMMARYThirty-six patients who suffered a recurrence of thyro-toxicosis after subtotal thyroidectomy have been retro-spectively analysed. After 11 subsequent second operations,7 further relapses occurred while 2 patients had permanentrecurrent laryngeal nerve paralyses. Only 1 patient out of18 treated with either long-term neomercazole or beta-adrenergic blockade remained in remission. Radio-activeiodine is the treatment of choice in patients who relapseafter surgery for thyrotoxicosis.A significant percentage of thyrotoxic patients treated bysubtotal thyroidectomy have a recurrence of the hyper-thyroid state.'" Attention has recently been focused onthe management of such patients; in particular the poorresults of surgery in such recurrent cases have beenemphasized: This report concerns a retrospective analysisof the management of 36 thyrotoxic patients seen at GrooteSchuur Hospital who had a recurrence of hyperthyroidismafter thyroidectomy.PATIENTS Mm METHODSThirty-six patients (34 females and 2 males) had all beenseen and at some stage followed up at the EndocrineClinic of Groote Schuur Hospital after thyroidectomy forthyrotoxicosis. Recurrence was diagnosed on the usualclinical criteria and confirmed in all cases by elevation ofthe 6- and 24-hour 1311 neck uptake, the protein-boundiodine (PBI) and the red cell uptake of tri-iodothyronine.While many of the patients were under regular follow-upat the Endocrine Clinic, a number who were living inother cities were not traced at the time of this study buthad been previously investigated at Groote Schuur Hospi-tal at the time of the recurrence of the disease. Currentclinical status, where possible, was either assessed person-ally, or by means of a questionnaire sent to the patientand/ or attending practitioner.RESULTSTime of Relapse After ThyroidectomyThe time of relapse after surgery is shown in Fig. 1.Twenty-one patients (60%) had relapsed within 4 years ofsubtotal thyroidectomy. In 4 cases this occurred within6 months of operation. At the other end of the spectrum,4 patients relapsed after 21 years or more.Therapy Given for Recurrence1. Repeat thyroidectomy: Ten patients had a secondsubtotal thyroidectomy and 1 of these subsequently hada third operation for a further relapse. There have been7 further recurrences after these 11 operations. Four ofthese recurrences have occurred within 2 years, 1 within4 years, 1 at 8 years and 1 at 13 years. Of the 4 patientsin whom recurrence has not occurred after a secondoperation, follow-up has been for only 1 year in 2 cases,2 years in a further case and 7 years in the last instance.'Date received 2 February 197I.tPresent address: Department of Surgery, Wayne State University Schoolof Medicine, Detroit, Michigan, USA.Following 2 of the 11 operations, recurrent laryngealpalsy developed. The incidence of hypoparathyroidism inthis group could not be meaningfully assessed as serumcalcium estimations were obtained in only 4 cases. Innone was hypocalcaemia evident.After the second relapse, 3 patients have been success-fully treated with 1311 and are euthyroid, while 3 of theremainder are currently controlled by antithyroid medica-tion and are not in remission.2. Long-term neomercazole. Eight of the 36 patients hadtheir recurrence treated by neomercazole for a minimumof 6 months. Only 1 such patient was considered euthyroidby clinical and investigative criteria after this time. Theremainder were either treated definitively with l3l1 (5 cases}or are being maintained on neomercazole (2 cases).3. Beta-adrenergic blockade alone. Ten patients in re-lapse were treated solely with propranolol 40 mg q.i.d.which effectively controlled the signs and many of the-symptoms in most cases. However, "'I uptake and PBIremained abnormal and on stopping propranolol, symp-toms and signs returned in all cases. As a result, 9 of the-10 patients have subsequently received l3l1 therapeutically.4. l3l1 therapy. Eight patients received 1311 therapy imme-diately after recurrence was diagnosed, 3 following recur-rence after a second subtotal thyroidectomy, while a fur-ther 14 patients received this form of therapy after varyingperiods on either antithyroid medication or beta.-adrenergicblockade.The satisfactory control of the hyperthyroid state fol-lowed 4 - 10 miIlicuries of I31I in all but 1 case, who needed16 millicuries. The period of time before euthyroidism wasachieved varied from months in some cases to up to ayear in others. The patient needing 16 millicuries was onlycontrolled after 2 years. Follow-up period has been too-short to assess the true incidence of hypothyroidism fol-lowing the administration of radio-active iodine in thesecases. However, 2 patients are already hypothyroid and are.on permanent thyroxine replacement therapy.10.;zYEARSFig 1. Time of relapse after thyroidectomy.12 Junie 1971 S.-A. MEDIESE TYDSKRIF 647DISCUSSIONThere is a very wide variation from series to series inthe incidence of recurrence of hyperthyroidism after sub-total thyroidectomy. While the average figure is around5%,],·,7 the incidence has varied from as Iow as 1'2%,"to 27·9%'-Sixty per cent of our patients relapsed within 4 yearsof operation, a percentage somewhat lower than thatreported by Cattell et al" who found that 76% of recur-rences after subtotal thyroidectomy were experiencedwithin 3 years of the operation. McLarty et al: reportedfigures similar to ours: 55% of their patients relapsedwithin 5 years after surgery. Yet surveillance after sub-total thyroidectomy must continue indefinitely, for patientsmay relapse many years after the operation-as occurredin 4 patients in this series.It was sucrgested by Taylor and Painter]· that recurrenceafter surger~ was related to the volume of thyroid tissueleft at operation. This is not the feeling of most authorsas the incidence of recurrence is not related to a singleoperator' (in this study many surgeons perfor~ed. thethyroidectomies) and various volumes of thyrOId tIssuehad been left by the different surgeons. Unfortunately theamount of the thyroid tissue left behind after the initialoperation could not be meaningfully assessed in thisretrospective study. While very early recurrence couldpossibly be explained by the size of the thyroid remnant,it is hard to believe that this is true of later recurrences.There appears to be a small but significant number ofthyrotoxic patients in whom the stimulus t~ t~yroid .hyper-plasia remains intense and prolonged. It IS ImpossIble atpresent to predict such patients in wJ,om the removal of80% or 90% of the thyroid gland will merely lead to aninterim remission until such time as the remainder becomeshyperplastic enough for thyrotoxicosis to recur. <?n theother hand in some patients, for example those ID ourseries who relapsed only after 10 years, recurrence wasprobably due to a fresh 'bout' of thyrotoxicosis. as thecyclical nature of this disease .has long been. rec~gmzed.It remains to discuss the rational therapy ID thiS group ofpatients. The consensus of opinion tha.t furthe~ attempts. atsubtotal thyroidectomy are fraught With conSIderable fIskas regards damage to the recurrent laryngeal nerves (?fwhich 2 examples are cited in this article) and parathyrOIdglands. The folly of su:::h surgical interv' ntion is heightenedby the observation in this series (and in others) of theenormous incidence of further recurrence after the secondoperation. Seven of 11 su:::h pati:nts in our study showed,a recurrence and all of 9 patients of McLarty et al.' hada similar outcome. In the recent raper by Hedley et al.,]5 of 6 patients suffered a recurrence under similar ~irc.um­stances. Second operation can therefore rarely be Justifiedin recurrent thyrotoxicosis. A possible exception may besevere compression of the trachea causing respiratorydistress, when relief of obstruction becomes an urgentproblem. Such a patient was recently seen by one of us(G.B.). .Antithyroid medication with or without. ?eta-adrenerlS!cblockade cannot be considered as defimtJve therapy IDthis situation as the very factors which tend to fav?urrecurrence after surgery would favour relapse after WIth-drawal of antithyroid medication. Solomon et al." con-firmed that antithyroid drugs were less effective in obtain-ing permanent remission in patients with postoperativ.erecurrence as opposed to those with primary hyperthyrOi-dism. The experience of McLarty et al.' confirms thisobservation while only 1 of 18 patients in this series onlong-term neomercazole or adrenergic blockade obtainedremission.Ablation of the thyroid with radio-active iodine wouldseem to be the therapy of chcice in this difficult situa-tion. In all but 1 of our patients given from 4 - 10 milli-curies of 1311, euthyroidism returned within a year. Anexceptional patient needed a total of 16 miIIicuries givenover 2 years before remission. In this series follow-up hasbeen too short to assess the incidence of hypothyroidism.This has been reported to be high, possibly significantlygreater in patients who have had a previous thyroidec-tomy." Greig" reported an incidence of 41 % in a 1- to 8-year follow-up, while Nofal et al. H found 51 % in asomewhat longer surveillance. Thus vigilance after success-ful therapy with radio-active iodine must be as greatas after any other form of therapy.What is the risk of thyroid neoplasia in young peopletreated with radio-active iodine? This question is highlypertinent, as the majority of patients with recurrence afterthyroidectomy are aged 20 - 35 years, a group consideredby some authorities to be too young to receive 1311 asdefinitive treatment in the first instance. In a number ofmajor studies,"'17 the occurrence of late carcinoma in thethyroid has not been shown to be more frequent thancould be accounted for by chance alone, although non-neoplastic nodules are described." Leukaemia has not beenfound. Furthermore, of 56 1311 treated young female patientsreported in one series," 28 had 52 normal children, while6 of 17 male patients had 17 normal children. Thereappears therefore to be no serious long-term risk ofeither malignancy or foetal abnormalities associated withthe therapeutic use of 1311 in hyperthyroidism. However,there is probably much more to be learned about its laterhazards, so 1311 should not be used as a routine in youngpeople as the first line of treatment. However, in post-thyroidectomy recurrence of hyperthyroidism we regardit as the regimen of choice as other therapy has provedmost unsatisfactory.Do not close the 'casebook' on patients who have hadwhat appears to be an immediately mccessful subtotalthyroidectomy for thyrotoxicosis. Quite apart from othercomplications of surgery which are not relevant to thisreport, the incidence of recurrent hyperthyroidism is sig-nificant. It must be anticipated in the individual case whenrapid regrowth of the thyroid remnant occurs. Such patientsmust be carefully watched even though they might beeuthyroid at the time. If recurrence does occur and hasbeen confirmed by appropriate investigation, therapeuticablation with 4 - 6 millicuries of ]311 is recommended.REFERENCESI. Hedley, A. J., FJemming, C. J., Chesters, M. I., Michie, W. andCrooks, J. (1970): Brit. Med. J., I, 519.2. Ray, A. D., Allan, J. and Harden, R. McG. (1967): Lancet, 2, 684.3. McNeill, A. D. and Thompson, J. A. (1968): Bnt. Med. J:, 3, 643.4. Bertelsen, A., Christensen, E., Braun, E. and Becker,Chnstensen, P.(1947): Acta chir. scand., 96, suppl. 133, p. 3.5. McLarty, D. G., Alexander, W. D., Harden, R. McG. and Clark,D. H. (1969): Brit. Med. J., 3, 200.6. Bow.er. R. F. (1966): Amer. Surg., 32, 89.7. Wilson: G. M. (1967): In Symposium of Thyroid Diseas~ and CalciumMetabolism, p. 51. Edinburgh: Royal College of PhYStClans.648 S.A. MEDICAL JOURNAL 12 June 19718. Reeve, T. S. (1964): J. Coli. Radio!. Aus., 8, 104.9. Cattell, R. B., Aiford, A. W. and Bartels, E. C. (1952): J. Clin.Endocr., 12, 1389.10. Taylor, G. W. and Painter, N. S. (1962): Lancet, I, 287.11. Solomon, D. H., Beck, J. C., Van der Laan, W. P. and Astwood,E. B. (1953): J. Amer. Med. Assoc., 152, 201.12. Dunn, J. T. and Chapman, E. M. (1964): New Eng!. J. Med., 271, 1037.13. Greig, W. R. (1966): Seot. Med. J., 11, 307.14. Nofal, M. M., Bierwalters, W.· H. and Palno, M. E. (1966): 1. Amer.Med. Assoc., 197, 605.15. Sheline, G. E., Lindsay, S., McCormack, K. R. and Galante, M.(1962): J. Clin. Endocr., 22, 8.16. Starr, P., Jaffe, H. L. and Oeuinger, L. jnr. (1969): J. Nuc!. Med.,10, 586.17. Cri le, G. jnr, Shumacher, P. (1965): Amer. J. Dis. Child., 110, 501.IN DIE VERBYGAAN : PASSING EVENTSUniversiteiI van die Oranje-Vrystaat, en Bloemfonteinse Oplei-dingshospitale. Die weeklikse vergaderings vind as volg plaas:Maandagaand 21 Junie om 2000 in die Lesingsaal, NasionaleHospitaal, sal daar 'n simposium gehou word oor die waardevan sitologiese ondersoeke. Prof. D. J. J. van Velden sal assameroeper optree.Vrydagmiddag 18 Junie om 1500 in die Lesingsaal, Pelonomi-hospitaal sal daar 'n bespreking gehou word oor Sir WilliamOsier en sy bydrae tot die kliniese geneeskunde. Prof. F. P.Retief sal as inleier optree.Saterdagoggend 19 Junie om 0930 in die Lesingsaal, Pelo-nomi-hospitaal sal 'n voordrag gelewer word deur die Depar-tement Patologie. Alle geneeshere wat belangstel word vriende-lik uitgenooi om hierdie byeenkomste by te woon.Daar word ook elke Vrydagmiddag om 1600 'n gesament-like kliniese bespreking gehou in die Lesingsaal van diePelonomi-hospitaal deur die Departement Chirurgie en InterneGeneeskunde, gevolg deur 'n gekombineerde radiologiebespre-king om 1700.South African Institute for Medical Research, Johannesburg,Staff Scientific Meetings. The next meeting will be held onMonday 21 June at 1710 in the Auditorium, North Block,SAIMR. Dr Ingram Anderson will speak on 'Not of genes orgenius'. All interested persons will be welcome.Universiteit van Stel/enbosch ell Karl Bremer-hospitaal, Klinies-patologiese Besprekings. Die volgende vergadering vind plaas opDinsdagmiddag 22 Junie om 1600 in die Dagkamer, IsteVloer, Karl Bremer-hospitaal, Bellville, K.P. Dr. R. S. BJakesal as spreker optree oor 'Die gebruik van diuretika'.Alle dokters wat belangstel word vriendelik uitgenooi om dievergadering by te woon.Kliniese besprekings word ook gereeld om 0900 elke Sater-dagoggend gehou in die Groot Voorlesingsaal, Karl Bremer-hospitaal, en is oop vir bywoning deur dokters.* * '"****'"*University of Cape Town and Association of Surgeons ofSouth Africa (MA.SA.), Joint Lectures. The next meetingwill be held on Wednesday 16 June at 1730 in the E-floorLecture Theatre, Groote Schuur Hospital, Observatory, Cape.Dr A. Naude will speak on 'Cancer immunology'.Universiteit van Pretoria, Chirurgiese Afdeling, en PretoriaTak van Vereniging van Chirurge van Suid-Afrika (MY.SA.),Gekombineerde Lesings. Die volgende vergadering vind plaasop Maandag 21 Junie om 1700 in Saal 114, B.M.W.-gebou,H. F. Verwoerd-hospitaal, Pretoria. Prof. R. C. Franz sal asspreker optree oor 'Thrombo-elastografie'.University of Cape Town and Groote Schuur Hospital, Divi-sion of Medicine: Postgraduate Programme. The followingmeetings in the Division of Medicine are held at GrooteSchuur Hospital and are open to interested postgraduatestudents and practitioners:Wednesday, at 0830: Paediatric case conference, FalconerLecture Theatre.Wednesday, at 1315: Lecture or seminar for medical regis-trars, Falconer Lecture Theatre (alternate Wednesdays).Thursday, at 1600: c.P.c. or special lecture, Falconer LectureTheatre.Thursday, at 1700: Clinical meeting, Falconer LectureTheatre.Friday, at 1700: Medical case conference, Falconer LectureTheatre.Saturday, at 0830: Interdepartmental case conference,Falconer Lecture Theatre.The meetings are ordinarily held between February andmid-November inclusive. Most are omitted during the Julyvacation; some are omitted during the Easter and Septembervacations.The following meetings are held at Red Cross War MemorialChildren's Hospital:Tuesday, at 0800: Joint surgical-paediatric case presentation,3rd-floor Lecture Theatre.Thursday, at 1300: Registrars' tuition meeting, often onpathological subjects, 3rd-floor Lecture Theatre.Friday, at 0800: Paediatric case presentation, 3rd-floorLecture Theatre.Saturday, at 0815: Paediatric Journals Club, 3rd-floor LectureTheatre.**'"*'"'"Universiteit van Ste/lenbosch en Karl Bremer-hospitaal, Sim-posium oor Respiratoriese Siektes. 'n Simposium oor respirato-riese siektes sal van 21 tot 22 Junie gehou word in dieDagkamer, lste Vloer, Karl Bremer-hospitaal, Bellviile, K.P.Die openingsrede sal deur prof. A. J. Brink gelewer word om0900 op Maandag 21 Junie. Die Voorsitterstoel sal onder-skeidelik deur pIOfs. M. A. de Kock, S. J. Saunders, F.Ziady, B. T. le Roux, A. J. Coleman en C. H. Wyndhambeklee word.Die volgende referate sal gelewer word: PhysiologicalEffects of Acute Changes in Altitude from Johannesburg toSea Level-dr. C. H. Wyndham; Experience with an IntensiveCare Unit for Children~drr. M. D. Bowie en S. G. Higgs;Gas Chromatography-prof. A. J. Coleman; The NewApproach to Tuberculosis-dr. T. F. B. Collins; The Carbon-dioxide Resistance and Relative Cardiac Failure-dr. R.Holloway; The use of the Infant J circuit in the Ventilation ofNeonates with Respiratory Insufficiency-dr. S. C. Bloch; FatEmbolism~dr. M. Plitt; Positive-negative Pressure Endotra-cheal Mucus Clearance~dr. S. H. Ripley; Chronic LungAbscess: A Problem in Diagnostic Radiology-prof. B. T. leRoux; Geskiedenis van die Stetoskoop--dr. H. Dubovsky;Kerosene Poisoning in Primates-dr. J. Wolfsdorf; AntitrypsinDeficiency-prof. M. A. de Kock; Management of Hypo-capnoeic Respiratory Failure-prof. H. v. Hassel en dr. 1. W.P. Obel; Medianoscopy-dr. P. Marchand; BrongodilatorieseMidde1s~prof. J. Offermeier; Revision of some of the RecentConcepts of Mucous Transport in the Pulmonary Airways-dr. A. van As; Respiratoriese Virusse-prof. W. B. Becker;Pneumoconiosis in South Africa~dr. G. K. Sluis-Cremer; TheBlood Gases and Acid Base of Infective Group-dr. A. G.Wesley; Post-troumatiese Long-dr. J. R. Joubert; Ondervin-ding met Heksaprenaline~dr. 1. Verm?ak: AanhoudendePositiewe Druk Ventilasie (C.P.P.B.)--prof. M. J. Ungerer;Sitologie van Brongiale Spoelings en Brongiale Borsels-prof.W. A. van Niekerk; Destructive Suppurative Pneumonia-dr.W. M. Pitt Fennell; The Mechanical Efficiency of the Respira-tory Muscles at Increased Lung Volume: An ExperimentalStudy-dr. A. R. Bosman; Asphyxia Neonatorum due to foam-ing of Pulmonary Fluid-dr. M. Klein; The affects of MaternalAnaesthesia on Acid-base Status of the Newborn-prof. H. deV. Heese.Maandagmiddag 21 Junie om 1600 sal die stigting van dieSuid-Afrikaanse Vereniging van Respiratoriese Siektes plaas-vind en dieselfde aand om 2000 sal 'n dinee gehou word.

The management of recurrent thyrotoxicosis after thyroidectomy

https://www.ajol.info/index.php/samj/article/download/170346/159776

The management of recurrent thyrotoxicosis after thyroidectomy

Abstract

Similar works

Full text

Available Versions

AJOL - African Journals Online